Is Jiahe Kangmei worth buying?

Worth applying for. The company belongs to the science and technology innovation board and is affected by the new regulations. Sub-sectors belong to medical informatization, and the overall industry market is developing rapidly, with a large space. In terms of financial situation, we turned losses into profits and achieved rapid growth this year. The listing valuation is high, but considering the company's outstanding performance, rapid industry growth, large potential space and low risk of breaking, the new comprehensive score is 70.

1. Jiahe Kangmei (Beijing) Technology Co., Ltd. was established on March 3, 2006, with its registered address at Floor 2, Building 1 201Room, Shangdi Information Industry Base, Haidian District, Beijing, and its legal representative is Xia Jun.

Two, computer software technology development, technology transfer, technical consultation and technical services; Application software services; Wholesale electronic products; Goods import and export, technology import and export, agent import and export (not involving state-owned trade management commodities; Where commodities subject to quota license management are involved, the application procedures shall be handled according to the relevant provisions of the state).

Three. Medical device production (subject to the medical device production license, limited to production in the production and operation place); Wholesale of medical devices (with medical device business license). (Market entities independently choose business projects and carry out business activities according to law; Projects that must be approved according to law shall, after being approved by the relevant departments, carry out business activities in accordance with the approved contents; Shall not engage in business activities of projects prohibited or restricted by the industrial policies of the state and this Municipality.

4. The "Joint Laboratory of Artificial Intelligence and Big Data of Traditional Chinese Medicine" jointly established by the first key laboratory of internal medicine of traditional Chinese medicine of Haisen Health Joint Education Department-Beijing University of Chinese Medicine was officially unveiled at Dongzhimen Hospital of Beijing University of Chinese Medicine, which became a major milestone in the introduction of big data and artificial intelligence technology into the field of traditional Chinese medicine.

5. The Standard Data Set of Inflammatory Bowel Disease (202 1 version) jointly compiled by the First Affiliated Hospital of Sun Yat-sen University, the Sixth Affiliated Hospital of Sun Yat-sen University, Peking Union Medical College Hospital of China Academy of Medical Sciences and Shaw Hospital was officially released by People's Health Publishing House.

6. The overall solution of Haisen Health Intelligent Pre-diagnosis Service was successfully selected into the public list of big data products and solutions for epidemic prevention and control and resumption of classes issued by the Ministry of Industry and Information Technology in 2020.